Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fernando Mendez-Hermida"'
Autor:
Angel Aledo-Serrano, Antonio Gil-Nagel, Julian Isla, Ana Mingorance, Fernando Mendez-Hermida, Ruben Hernandez-Alcoceba
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-3 (2021)
Abstract The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenovi
Externí odkaz:
https://doaj.org/article/693f95cb49044abbacb22bcfef793a34
Autor:
Fernando Mendez-Hermida, Julian Isla, Ruben Hernandez-Alcoceba, Antonio Gil-Nagel, Ana Mingorance, Ángel Aledo-Serrano
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-3 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenoviruses (Ad
Autor:
Segundo Mariz, Fernando Mendez-Hermida, Violeta Stoyanova-Beninska, Maria E. Sheean, Laura Fregonese, Dinko Vitezić, Armando Magrelli, Nikolaos V. Sipsas, Tim Leest, Stelios Tsigkos, Dinah Duarte, Bruno Sepodes, Eva Malikova, Robert Nistico, Giuseppe Capovilla, Matthias P. Hofer, Kristina Larsson
Publikováno v:
Drug Discovery Today
Volume 25
Issue 2
Volume 25
Issue 2
The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) is responsible for evaluating applications for orphan designation (OMPDs) and for deciding the orphan status at the time of marketing authorization of medicines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58e9b1e4b49f0c050ffbef7f5ce2103
http://hdl.handle.net/2108/227456
http://hdl.handle.net/2108/227456
Autor:
Fernando Mendez Hermida
Publikováno v:
Medical Entomology and Zoology. 52:114